BridgeMD
New treatment option for Cardiovascular System
Official title Acute Effects of Cold Exposure on Cardiovascular System
ClinicalTrials.gov ID: NCT06652425
What this study is testing
- What it's testing
- This is a randomized controlled human exposure crossover study. Investigators aim to assess the acute effects of low temperature exposure on cardiovascular system and the underlying mechanisms.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30. Healthy volunteers may be eligible.
You may be able to join if
- Living in Shanghai during the study period;
- Body mass index \> 18.5 and ≤ 28;
- Right-handed;
- Receiving or having received higher education;
- With the ability to read and understand Chinese smoothly.
You likely can't join if
- Smoking and alcohol abuse;
- Current drug and dietary supplements intake;
- people with allergic diseases, such as allergic rhinitis, allergic asthma, and atopy;
- people with cardiovascular diseases, such as congenital heart disease, pulmonary heart disease, and hypertension;
- people with respiratory diseases, such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease;
- people with chronic diseases, such as diabetes, chronic hepatitis, and kidney disease;
See the full eligibility criteria
- Living in Shanghai during the study period;
- Body mass index \> 18.5 and ≤ 28;
- Right-handed;
- Receiving or having received higher education;
- With the ability to read and understand Chinese smoothly.
- Smoking and alcohol abuse;
- Current drug and dietary supplements intake;
- people with allergic diseases, such as allergic rhinitis, allergic asthma, and atopy;
- people with cardiovascular diseases, such as congenital heart disease, pulmonary heart disease, and hypertension;
- people with respiratory diseases, such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease;
- people with chronic diseases, such as diabetes, chronic hepatitis, and kidney disease;
- people who have a history of major surgery due to cardiovascular, cerebrovascular, respiratory, or neurological diseases;
- people with neurologic disorders, such as stroke, traumatic brain injury, epilepsy, and schizophrenia;
- Abnormal spirometry (FEV1 and FVC ≤ 75% of predicted and FEV1/FVC ≤ 0.65);
- people with color vision disabilities.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.